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ABSTRACT 
Objective: The aim of this investigation was to compare the release behavior of propranolol HCl from simple matrix and layered 
tablets containing HPMC and phytowax as matrix component using direct compression technique.  
Method: The test of drug release was performed in distilled water during 26 hrs using a dissolution apparatus and thereafter the 
dissolution profile fitting to different mathematical equations was carried out using least square fitting with a nonlinear computer 
program, Scientist for Windows, version 2.1. 
Results: Covering both planar surfaces of drug-loaded middle layer was able to attain a more sustainable drug release than a 
simple matrix which composed the same amount of matrix component. Additionally, the near-zero order release could be 
obtained for the first system whereas the drug release from simple matrix tablet was diffusion-controlled. As the number or 
amount of coating layer, and amount of matrix component in middle layer were increased, the drug release was noticeably 
prolonged. Drug release from layered tablets was influenced by hydrodynamic force and incorporated diluents. 
Conclusion: Effective near-zero order controlled release of hydrophilic drug was obtained from three-layered matrix tablets 
comprising HPMC as main matrix component. Modulation of drug release could be conducted by addition or increasing amount 
of water soluble substances into the matrix component of three-layered tablets. 
Key words: drug release, comparison, simple layered-matrix, layered-matrix, hydroxypropyl methylcellulose 
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Introduction 
§Hydroxypropyl methylcellulose (HPMC) is non-ionic 
aqueous-soluble cellulose ether derivative for a use in 
controlled-release dosage forms. Owing to high 
swellability and high gelling strength formation this 
polymer effectively prolongs drug release which has a 
significant effect on the release kinetics of an 
incorporated drug. Profound discussion of the 
mathematical modeling for drug release from HPMC-
based delivery devices has been reviewed and 
described.1 Typically, surface area/volume is one of the 
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key variables in controlling drug release and can be 
employed to modulate drug release from tablet.2 Design 
parameters such as the geometry or the amount and 
hydrophilicity of incorporated diluents should be 
considered as the important aspect when developing the 
effective controlled-release systems. Suitable geometric 
design of matrix systems has been employed to 
modulate drug release behavior. One of useful 
techniques is based on the fabrication of matrix into 
three-layer tablets. Select polymeric matter used in this 
system plays an important role in the modulation of drug 
release. The barriers made of HPMC seem more efficient 
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in reducing drug delivery than poly(ethylene oxide) (PEO) 
barriers, and their efficiency in drug release modulation 
depended on the viscosity generated from polymer.3 
Layering with polymeric matrix containing chitosan and 
xanthan gum could prolong the drug release in HCl 
buffer pH 1.2 and shift the release pattern approach to 
zero order.4 In addition, increasing the amount of this 
matrix component in coating layer or in core tablet could 
apparently prolong the drug release.  
Several variables, such as the presence of diluents 
and compression force could modify the drug release 
from the simple monolithic matrices.5,6 The varying 
loading dose of diltiazem HCl in three-layer tablets 
(prepared using polyethylene oxide combined with HPMC 
K4M) did not affect the drug release behavior.7 However, 
an increase in stirring rate during dissolution of those 
systems enhanced the drug release rate with the linearity 
of release profiles remained unaltered.  
Gastrointestinal drug absorption from developed 
dosage forms is reflected by in vitro dissolution rate. 
Agitation intensity, hydrodynamic force and hydrodynamic 
condition could influence the drug dissolution rate in 
dissolution medium during dissolution test or during drug 
distribution in gastrointestinal tract. As the agitation 
intensity of the paddle or the basket increased, the 
percent drug dissolved from tablets and mass transfer 
coefficient were increased, but the film thickness was 
diminished.8 Most previous investigations have been 
concentrated on effect of the type of polymer and drug or 
compression force used, with scant attention given to 
test the effect of amount of coating barrier or middle 
layer, and the adjustment of matrix hydrophilicity on 
release characteristic of three-layer tablets.  
The purpose of this study is to investigate the effect 
of the amount of coating barrier or middle layer on the 
drug release from layered matrix tablets comprising 
HPMC K15M and phytowax as the main matrix 
component. Effect of an addition of hydrophilic 
substances into the system was also studied. Propranolol 
HCl was used as the model drug in this study.  
 
 
Materials and Methods 
 
Materials 
Hydroxypropyl methylcellulose (HPMC) type K15M, 
lot No. PH26012N31 (Dow Chemical, USA) was used as 
received. Propranolol hydrochloride (Batch No. 941002) 
was purchased from China National Chemical Imp. & 
Exp., Shanghai, China. Magnesium stearate (Lot No. 
MAF 07, P. C. Drug Center Co.) was passed through 
sieve No. 80 mesh before use. Phytowax (PhytowaxÒ 
Olive 14L 48, hydrogenated myristyl esters of olive oil), 
purchased from Sophim, Parc de la Cassine, France), 
Avicel PH 101 (Lot no. 2784, Asahi Chemical Industry, 
Japan), polyethylene glycol 4000 (PC Drug, Thailand), 
sodium bicarbonate (AF310196, Asia Pacific Specialty 
Chemicals Ltd., NSW, Australia) were passed through 
sieve No. 60 before use and sodium chloride (Lot 
k20420804, Merk, E Merck, Darmstadt, Germany) was 
used as received. All other reagents were of analytical 
grade. 
 
Preparation of Matrix Tablets 
The single layer 200-mg tablets containing 
propranolol HCl were prepared by direct compression. 
The concentration of drug was kept constantly at 80 
mg/tablet. To make the powder mixture, 40% w/w drug, 
23 %w/w phytowax and 35 %w/w HPMC were mixed 
with 2% w/w magnesium stearate for 10 minutes using 
mortar and pestle. Then the blended powder of 200 mg 
was compressed into a tablet at a compression force of 
1.5 tons using 12 mm round, flat and plain punches 
using a hydraulic press (Carver Press, WI). The 
combined two- or three-layered tablets containing 35% 
w/w HPMC were also prepared with the composition 
formula as shown in Table 1 using the method previously 
mentioned. For layered tablets, there was a barrier layer 
on upper or lower part of core tablet. Layered matrix 
tablets were prepared by adding the preweighed amount 
of the powder mixture without drug (containing 2% 
magnesium stearate) in the die cavity and the 
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preweighed amount of the powder mixture with drug was 
placed over the first layer compressed with a 1.5-tons 
force using a hydraulic press to obtain the two-layer 
tablet. The dwell time after target pressure achieved was 
10 sec. To prepare the three-layer tablet, the preweighed 
amount of the powder mixture without drug was placed 
over the well spread second layer and was compressed 
with a 1.5-tons force. The three-layer tablets with 
different amount of barrier (100, 150 and 200-mg for 
each side of barrier) were prepared using the formulation 
containing 35 %w/w HPMC (Table 2). For the formula, 
the number before the letter “L” in the first term of 
formula represents the number of layer, and the first and 
third number in the second term multiply with 100 
represents the amount (mg) of each barrier layer and the 
second number in the second term multiply with 100 
represents the amount (mg) of core tablet. Layered 
tablets containing 10 or 20%w/w different additives (PEG 
4000, Avicel, sodium chloride and sodium bicarbonate) 
were also prepared. 
 
Table 1 Percent composition of different single layer 
formulations containing lactose. 
Formulation (mg) 
Substances Core tablet 
(1L 2) 
Combined 2-
layered tablet 
(2L combined) 
Combined 3-
layered tablet 
(3L combined) 
 Propranolol HCl 80 80 80 
 HPMC 70 140 210 
 Phytowax 46 172 298 
 Magnesium stearate 4 8 12 
 Total 200 400 600 
 
 
Table 2 Composition of barrier. 
 
The Evaluation of Matrix Tablets 
The hardness of tablets was determined using a 
hardness tester (Pharmatest, USA). The tablet thickness 
was measured using a thickness tester (Teclock, Japan). 
The friability was determined as the percent weight loss 
from 20 tablets. Twenty tablets were weighed and 
rotated for 100 revolutions in 4 min in a friabilator 
(Yieheng Engineering, Bangkok, Thailand). A test of drug 
release was undertaken using a dissolution apparatus 
(type 1) (Prolabo, France) with the basket method at 100 
rpm. A 900-mL distilled water equilibrated at 37 °C was 
used as dissolution fluid. Samples were collected at 
specific time intervals and assayed by a UV-Vis 
spectrophotometer (Perkin-Elmer, Germany) at a 
wavelength of 320 nm. The operation was continued until 
completing 26 hours. During the drug release studies, 
the tablets were observed for physical integrity. To study 
the effect of hydrodynamic force on drug release, the 
tablets were tested for dissolution at different basket 
rotational speeds of 50, 100 and 150 rpm.  
 
Dissolution Profile Fitting 
Least square fitting the experimental dissolution data 
(cumulative drug release > 10% and up to 80%) to the 
mathematical equations (power law and zero order) was 
carried out using a nonlinear computer program, Scientist 
for Windows version 2.1 (MicroMath Scientific Software, 
Salt Lake City, UT, USA). The coefficient of 
determination (r2) was used to indicate the degree of 
curve fitting. Goodness-of-fit was also evaluated using 
the Model Selection Criterion (MSC)9, given below.  
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Where Yobsi and Ycali are observed and calculated values 
of the i-th point, respectively, and wi is the weight that 
applies to the i-th point, n is number of points and p is 
number of parameters. 
Substance Formulations (mg) 
HPMC 70 
Phytowax 126 
Magnesium stearate 4 
Total 200  
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Results and Discussion 
The Physical Properties of Matrix Tablets 
The data on weight, thickness, friability and hardness 
of single, combined and layered tablets are presented in 
Table 3. The hardness of tablet tended to increase as 
the amount of matrix or barrier was increased. The rather 
high % friability (>1%) was found in case of 1L 2 and 
layered-tablets of NaCl10% 2L 2/2 and NaHCO310% 3L 
2/2/2. Replacement of phytowax with other additives 
except sodium chloride enhanced the tablet hardness. 
Since this production was one step manufacturing 
process, the commercial products can be scaled up by 
the high speed three-layer tableting machines. 
 
Table 3 Physical properties of prepared tablets. 
Formulation 
Weight ± S.D. (mg) 
(n=20) 
Thickness ± S.D. (mm) 
(n=10) 
Friability  
(%) 
Hardness ± S.D. (Kp) 
(n=10) 
1L 2 200.6 ± 6.2 1.45 ± 0.02 1.91 2.54 ± 0.70 
2L 2/2 401.0 ± 6.5 3.19 ± 0.04 0.74 3.70 ± 0.21 
3L 1/2/1 403.3 ± 8.5 3.18 ± 0.20 0.62 3.21 ± 0.31 
3L 2/2/2 602.7 ± 10.1 4.38 ± 0.09 0.58 4.43 ± 0.19 
2L combined 402.4 ± 8.7 3.05 ± 0.06 0.51 1.12 ± 0.18 
3L combined 608.5 ± 6.9 4.54 ± 0.07 0.73 2.24 ± 0.33 
NaCl10% 2L 2/2 395.7 ± 8.3 2.90 ± 0.07 1.11 1.86 ± 0.41 
NaCl 10% 3L 2/2/2 603.6 ± 6.3 4.23 ± 0.09 1.44 3.44 ± 0.16 
NaCl 20% 3L 2/2/2 599.9 ± 6.9 3.96 ± 0.07 0.72 2.89 ± 0.48 
PEG4000 10% 3L 1/2/1 396.3 ± 6.4 2.70 ± 0.11 0.53 7.71 ± 0.46 
Avicel 10% 3L 1/2/1 403.8 ± 5.4 2.85 ± 0.05 0.41 5.34 ± 0.47 
NaHCO310% 3L 2/2/2 598.8 ± 9.6 4.55 ± 0.12 1.14 4.91 ± 0.30 
NaHCO3 20% 3L 2/2/2 598.0 ± 8.3 4.19 ± 0.04 0.81 5.25 ± 0.30 
 
In Vitro Drug Release
Apparent drug release prolongation could be attained 
for three-layered tablets (Fig. 1). By comparison with the 
same amount of component, the drug release retardation 
was more evident from three-layered tablets than that of 
combined tablets. Barriers without drug covering onto 
core tablet effectively modulated the diffusion of 
dissolved drug molecule into dissolution medium since 
they could diminish the drug deposited on tablet surface 
to expose the dissolution medium. Rather initial fast drug 
release was noticeable for the single layer or combined 
tablets because of rapid drug dissolution and outward 
diffusion from tablet surface. This evidence indicated that 
the high water soluble drug could rapidly diffuse from this 
compressed matrix. Drug release of 100% over 4 hr was 
ostensible for single-layered tablet. Slow release of 
combined tablet was due to the formation of a thick gel 
structure after extensive swelling of HPMC that delayed 
drug release from the tablet matrix. Combined three-
layered tablet showed greater retardation of drug release 
than combined two-layered tablet since higher amount 
matrix component promoted the longer distance for water 
penetration into tablet mass to dissolve the drug particles 
and for dissolved drug molecules inside matrix to diffuse 
outward into dissolution medium. Drug release rate from 
three-layer tablet was obviously less than that of two-
layer tablet and single-layered tablet, respectively. High 
gelling formation with the sticky property of HPMC 
promoted the good adhesion between layers during 
immersion of the layered tablets in a dissolution medium. 
Both covering barriers played importance role on 
retardation of drug release, since this layer diminished 
the contact area of core matrix to the dissolution 
medium. Therefore one of the benefits of using the three-
layer tablet was to reduce dose dumping for high 
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solubility drug substances. Additionally, this system could 
change the drug release behavior of typical simple matrix 
which would be subsequently analyzed. 
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Figure 1 Dissolution profiles of propranolol HCl from 
single-layered, two-layered, three-layered and 
combined tablets containing HPMC and 
phytowax in distilled water. Each point 
represents the mean ± S.D., n=3. 
 
Increasing amount of barrier apparently retarded the 
drug release as shown in Fig. 1. Drug release from the 
middle layer could be modified by the delayed diffusion 
from the two coated surfaces as a result of simple 
diffusion. From one planar drug release study, apparent 
lag time was observed for drug release of three-layer 
tablets and tended to prolong as the amount of barrier 
was increased.4 The result suggested that the barrier 
layer plays a significant role in modifying the lag time 
and the drug release. Increasing matrix quantity of 
barrier resulted in a substantial retardation of drug 
release. Therefore, the apparent release rate was 
determined by the summation of release rates from the 
lateral surface of middle layer and from two covering 
barriers, which would vary, depending on the formulation 
variables of the barrier layer including thickness and 
composition. 
Typically, agitation intensity or hydrodynamic force 
could influence drug release from dosage forms because 
of the alteration of drug diffusion rate. Effect of 
hydrodynamic force on drug release from prepared 
tablets was carried on using different rotational basket 
speeds during dissolution test. Increasing the basket 
rotational speed increased the drug dissolution from 
combined tablet and three-layer tablet as presented in 
Fig. 2. However, the drug release from three-layered 
tablet at 100 rpm was slightly slower than at 50 rpm. 
Therefore, the hydrodynamic force could affect the drug 
release of layered tablets. 
 
0
20
40
60
80
100
120
0 200 400 600 800 1000 1200 1400 1600
Time (min)
%
R
el
ea
se
 2L combined 50 rpm
 2L combined 100 rpm
 2L combined 150 rpm
3L 2/2/2 50 rpm
3L 2/2/2 100 rpm
3L 2/2/2 150 rpm
 
 
Figure 2 Effect of rotational speed on dissolution of 
propranolol HCl from combined tablet and 
three-layered tablets containing HPMC and 
phytowax in distilled water. Each point 
represents the mean ± S.D., n=3. 
 
Phytowax is the hydrophobic material which is 
hydrogenated myristyl esters of olive oil. Utilizing this 
material as matrix component decreased the 
hydrophilicity of the matrix tablet. Incorporating some 
additives influenced the drug release as presented in Fig. 
3. Water soluble additives including PEG4000 and 
sodium chloride apparently enhanced drug release. 
These two substances, by their water soluble and 
hydrophilic nature, facilitated HPMC gel formation and 
the time taken for the dissolution medium to permeate to 
the core was shorter as the amount of this soluble 
substance was increased. Moreover, soluble substance 
acted as a channeling agent, by rapidly dissolving and 
easily diffusing outward, therefore allowed a decrease in 
tortuosity and/or an increase in the matrix porosity.10-12 
The drug release from three-layered tablet containing 
sodium chloride was slower than that of two-layered 
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tablet. An addition or increasing amount of sodium 
bicarbonate noticeably retarded the drug release from 
three-layered tablets. Some research work indicated that 
the release rate of metoprolol tartrate was rather 
constant from polyethylene oxide containing electrolytes 
such as sodium bicarbonate since it changed the gel 
strength or there was the interaction of drug molecule 
with this substance.13 Electrolytes such as adipic acid 
and sodium deoxycholate in polyethylene oxide matrix 
could capture the water molecules from polymer and 
promoted the gel strength.14 Incorporation of sodium 
bicarbonate in the polymeric matrix (based on 
polyethylene oxide and HPMC) salted out the 
macromolecules and increased gel strength and gel 
viscosity has been reported.15 Therefore, the outward 
drug diffusion was controlled by an inwardly progressing 
water penetration and higher viscous gel structure from 
HPMC matrix. Sodium chloride was able to diminish the 
polymer hydration16,17 but due to its high water solubility 
it could enhance drug release. Similar result was also 
found for additions of PEG4000 and Avicel as shown in 
Fig. 3.  
 
0
20
40
60
80
100
120
0 200 400 600 800 1000 1200 1400 1600
Time (min)
%
R
el
ea
se
3L 2/2/2 Avicel 10%  3L 1/2/1
PEG 4000 10% 3L 1/2/1 NaCl 10%  3L 2/2/2
NaCl 10%  2L 2/2 NaCl 20%  3L 2/2/2
NaHCO3 10% 3L 2/2/2 NaHCO3 20% 3L 2/2/2
 
Figure 3 Effect of additives on dissolution of propranolol 
HCl from combined tablet and three-layered 
tablets containing HPMC and phytowax in 
distilled water. Each point represents the 
mean ± S.D., n=3. 
 However, Avicel increased drug release by 
enhancing tablet disintegration and promoting tablet 
erosion. Such similar effect of Avicel has been reported 
on drug release from acetaminophen bi-layered matrix 
tablet.18. The observed differences in the dissolution 
properties of the tablets were due to the differences in 
the solubility, swellability and density of the filler 
excipients. Therefore, the adjustment for type and 
amount of matrix component of the layered tablets 
exhibited as important factors affecting the modulating 
efficacy of the drug release. 
 
Dissolution Profile Fitting 
Large value of the coefficient of determination (r2) or 
model selection criteria (MSC) indicated a superiority of 
the dissolution profile fitting to mathematical equations. 
Comparison of goodness of fitting drug dissolution 
profiles to power law and zero order equations is 
presented in Table 4A. Additional fitting to first order and 
Higuchi’s was performed for drug release from combined 
tablet. Fitting experimental drug dissolution profiles to the 
power law equation provided high r2 (0.9955 to 0.9997) 
and MSC (5.00 to 7.82) indicating a superiority of this 
model. Estimate parameters from curve fitting to power 
law and zero order equations are shown in Table 4B. 
Kinetics of drug release from the developed matrices 
was analyzed using the power law expression. This 
equation (an empirical equation) gained popularity for 
analysis of release data.19 The n value from power law is 
the diffusional exponent which characterizes the transport 
mechanism of the drug. The transport mechanisms are 
classified based on the value that n assumes. For a 
cylinder, the drug transport mechanism is by Fickian 
diffusion when n = 0.45. If 0.45 < n < 0.89, it indicates 
anomalous (non-Fickian) transport. For values of n = 
0.89, case II or zero order release kinetics is indicated. 
Case II relates to polymer relaxation, while non-Fickian 
release is described by two mechanisms; the coupling of 
drug diffusion and polymer relaxation.19,21 The n values 
from the fitting of most drug dissolution profiles of 
combined, single-layered and two-layered tablets were 
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close to 0.45, indicating the nearly Higuchi’s release. 
Prominent better fit to Higuchi’s equation was observed 
for drug release from combined tablets as shown in 
Table 4A. Therefore, the drug release from these 
systems was the diffusion control. Similar result was 
reported for drug release from simple starch-borate-urea 
matrix tablet.22 Near zero order release was evident for 
drug release from three-layered tablets since large r2 and 
MSC values were obtained and the n value was close to 
0.84. These results suggested that the developed three-
layer tablets showed near zero-order or Case II release. 
The values of the kinetic constant (k) were in accordance 
with the values of n, the diffusion exponent, with k having 
lower values when the transport mechanism was Case II 
and higher values for systems that the drug release 
obeyed the Fickian diffusion kinetic. Alteration of these 
estimated parameters as mentioned above was 
previously mentioned.20,21 Compression with polymeric 
layer on both sides of middle tablet could prolong and 
modify drug release to achieve a constant release rate.  
 
Table 4 Comparison of degree of goodness-of-fit from curve fitting of drug dissolution to different release models (A) 
and estimate parameters (B) from curve fitting of drug dissolution to power law expression. 
(4A) 
Power law First order Higuchi’s Zero order Tablet 
r2 MSC r2 MSC r2 MSC r2 MSC 
1L 2 0.9995 6.65     0.9698  3.00 
2L combined 0.9997 7.75 0.9973 5.60 0.9989 6.45 0.9731 3.31 
3L combined 0.9990 6.58 0.9963 5.36 0.9990 6.62 0.9619 3.02 
2L 2/2 50rpm 0.9985 6.12     0.9985 6.12 
2L 2/2 100rpm 0.9990 6.55 0.9981 6.01 0.9966 5.41 0.9551 2.84 
2L 2/2 150rpm 0.9991 6.60     0.9548 2.81 
3L 1/2/1 50rpm 0.9997 7.82     0.9940 4.86 
3L 1/2/1 100rpm 0.9955 5.00 0.9843 3.89 0.9404 2.55 0.9939 4.83 
3L 1/2/1 150rpm 0.9994 7.04     0.9946 5.00 
  
   (4B) 
Tablet K ± S.D. *10-3   n  ±  S.D. 
1L 2 55.43 ± 6.14 0.5377 ± 0.0212 
2L combined 31.07 ± 1.26 0.5435 ± 0.0100 
3L combined 28.14 ± 1.81 0.5108 ± 0.0104 
2L 2/2 50rpm 23.39 ± 1.98 0.5299 ± 0.0132 
2L 2/2 100rpm 30.93 ± 1.75 0.5275 ± 0.0096 
2L 2/2 150rpm 35.75 ± 1.99 0.5148 ± 0.0096 
3L 1/2/1 50rpm 4.65 ± 0.37 0.7447 ± 0.0114 
3L 1/2/1 100rpm 3.84 ± 0.42 0.7818 ± 0.0154 
3L 1/2/1 150rpm 2.10 ± 0.95 0.8520 ± 0.0625 
 
Typically, the initial rapid drug release of deposited 
drug on matrix surface and the decreasing release rate 
at late state were exhibited for diffusion-controlled 
release of simple matrix. The layering on both planar 
surfaces of three-layered tablet with drug-free polymeric 
matrix by compression could diminish the initial rapid 
release and also delayed the medium penetration and 
hydration of middle layer. Therefore, the initial drug 
release was only from cylindrical side surface of tablet. 
Dissolved drug molecules gradually delayed diffusion 
through both covering barriers as a result of increasing 
polymer hydration/dissolution over time. External 
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hydrated barriers would disappear gradually with time 
and diffusional path-length was subsequently decreased 
promoting drug release at late state. Therefore the 
counterbalance was occurred as described above during 
dissolution test and the zero-order release could be 
achieved for three-layered matrix systems.7 Type and 
amount of covering barrier, therefore, affected directly the 
drug release rate of three-layered system. Fig. 4 shows 
photoimages of 3L 1/2/1 before and after dissolution at 
different time intervals. The gel was formed around the 
tablet after dissolution and the dimension of tablet was 
increased with time. However, the tablet dimension was 
decreased after dissolution for 26 hrs. High gel forming 
efficiency of HPMC could maintain the cylindrical shape 
during dissolution and there was no tablet disintegration 
in the late stage of dissolution. Although the drug 
diffused outward but with its high hydrophilicity this also 
enhanced the water penetration and promoted the 
polymer hydration with viscous texture therefore the 
apparent erosion of middle layer was not found 
 
  
  
  
 
Figure 4 Appearance of three-layered tablets (3L 1/2/1) after dissolution test in distilled water  
at different time intervals. 
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Replacement the amount of phytowax with some 
additives did not significantly shift the release kinetic 
since the n value signified the Case II release (Table 5). 
Lower k value from curve fitting to power law equation 
was found for three-layer tablet containing different 
additives but not for two-layered tablet. Addition of 
PEG4000 and sodium chloride or increasing amount of 
sodium chloride increased the drug release rate as 
shown from the result of curve fitting to zero order 
equation. Dramatic low release rate was found for drug 
release from tablet containing sodium bicarbonate. In 
addition, the n value higher than 1 for these tablets 
indicated the super case II which was found for upward 
or sigmoid profile drug releases.23,24 
 
Table 5 Comparison of degree of goodness-of-fit and estimate parameters from curve fitting of drug dissolution from 
three-layered tablets containing different additives to different release models. 
Power law Zero order 
Tablet 
r2 MSC K ± S.D. *10-3 n  ±  S.D. r2 MSC K  ±  S.D. *10-3 
NaCl10% 2L 2/2 0.9989 6.40 16.65 + 1.53 0.6411 + 0.0155 0.9789 3.58 1.73 + 0.00 
NaCl10% 3L 2/2/2 0.9984 6.01 1.42 + 0.40 0.9196 + 0.0393 0.9978 5.87 0.80 + 0.00 
NaCl20% 3L 2/2/2 0.9971 5.39 4.11 + 1.07 0.8026 + 0.0391 0.9924 4.57 1.07 + 0.03 
PEG4000 10% 3L 1/2/1 0.9980 5.66 6.21 + 1.50 0.8186 + 0.0393 0.9993 4.80 1.93 + 0.05 
Avicel 10% 3L 1/2/1 0.9998 8.38 5.34 + 0.30 0.7966 + 0.0088 0.9956 5.17 1.42 + 0.03 
NaHCO310% 3L 2/2/2 0.8225 1.27 0.23+ 0.3.99 0.9342 + 2.026 0.9850 3.99 0.18 + 0.00 
NaHCO3 20% 3L 2/2/2 0.9979 5.43 0.00 + 0.00 1.4607 + 0.2726 0.9903 4.13 0.24 + 0.01 
 
Conclusion  
At the same amount of matrix component, the design 
of the system into three-layered tablet which covered 
both planar surfaces with polymeric barrier more 
effectively prolonged drug release than simple matrix 
system. Interestingly, the near-zero order drug release 
was also achieved for three-layered tablets whereas the 
diffusion control mechanism was evident for drug release 
from simple matrix tablet. Increasing the amount of 
matrix component in covering barriers could apparently 
prolong the drug release. The drug release from two-
layered or three-layer tablet was influenced by 
hydrodynamic force. Drug release from three-layered 
tablet was noticeably increased after replacement of 
phytowax with hydrophilic excipients. Since this 
production was one step manufacturing process, the 
commercial products can be scaled up by the high speed 
three-layer tableting machines. 
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